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Abstract
Three adjacent single nucleotide polymorphisms of the vitamin D receptor gene (VDR)
BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236) are commonly studied in several
pathologies. We aimed to evaluate the distribution of VDR BsmI, ApaI, and TaqI allele,
genotype, and haplotype frequencies in an Italian cohort of 266 patients with lumbar spine
disorders assessed by Magnetic Resonance Imaging and 252 asymptomatic controls. The
exposure to putative risk factors was evaluated by a questionnaire. Polymorphisms were
detected by PCR-RFLP and TaqMan1 SNP Genotyping Assay. The results were statisti-
cally adjusted for the identified conventional risk factors. The three SNPs were in linkage
disequilibrium. For all cases BbAaTT was a 3-fold risk factor OR = 3.38), whereas bbAATT
(OR = 0.22), and bbaaTT (OR = 0.47) genotypes were found to be protective. Specifically,
for patients affected by disc herniation only (n = 88) and all lumbar pathologies excluding
stenosis and/or spondylolistesis (n = 215) B allele, Bb, Aa, and BbAaTT genotypes were
risky, whereas b allele, bb, aa, and bbaaTT genotypes were protective. In patients affected
by osteochondrosis with or without disc hernation (n = 50), T allele, Aa, and bbAaTT geno-
types were risky, whereas t allele, AA, tt genotypes were protective. In patients affected by
stenosis and/or spondylolistesis (n = 51) no significant associations were found. This is the
first study showing an association of the three genetic VDR variants BsmI, ApaI, and TaqI
and lumbar spine pathologies. Our study contributes to delineate genetic risk factors for
specific subgroups of patients with lumbar spine pathologies highlighting the importance of
haplotype analysis, and of detailed clinical evaluation of the patients for identification of
genetic biomarkers.
PLOS ONE | DOI:10.1371/journal.pone.0155004 May 5, 2016 1 / 15
a11111
OPEN ACCESS
Citation: Colombini A, Brayda-Bruno M, Lombardi G,
Croiset SJ, Ceriani C, Buligan C, et al. (2016) BsmI,
ApaI and TaqI Polymorphisms in the Vitamin D
Receptor Gene (VDR) and Association with Lumbar
Spine Pathologies: An Italian Case-Control Study.
PLoS ONE 11(5): e0155004. doi:10.1371/journal.
pone.0155004
Editor: Graham R. Wallace, University of
Birmingham, UNITED KINGDOM
Received: December 31, 2015
Accepted: April 22, 2016
Published: May 5, 2016
Copyright: © 2016 Colombini et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: Underlying participant-
level data cannot be made publicly available or be
included in the supporting information for ethical
reasons, due to patient’s privacy. All other relevant
data are within the paper and its Supporting
Information files.
Funding: This work was supported by European
Community’s Seventh 567 Framework Programme
(FP7, 2007–2013 under Grant Agreement 568 No.
HEALTH-F2-2008-201626) and by the Italian Ministry
of Health. The funders had no role in study design,
Introduction
BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236) are adjacent restriction fragment
length polymorphisms (RFLP) located in the region of intron 8/exon 9 of the vitamin D recep-
tor gene (VDR), which has been commonly associated with several diseases [1]. Furthermore,
they have been also associated with lumbar disc degeneration (LDD) [2–4]. These three single
nucleotide polymorphisms (SNPs), BsmI (G>A), ApaI (T>G), and TaqI (T>C), are located
close to the 3’ terminus of the gene, and do not determine structural modification in the recep-
tor [1]. There is no clear evidence about the effect of BsmI and ApaI variants in affecting the
VDR activity, whereas TaqI is a synonymous SNP [1]. Nevertheless, some authors hypothe-
sized some effects on mRNA stability [1,5]. These 3 SNPs were frequently reported to be in
linkage disequilibrium (LD). Moreover, it has been suggested that they could be in LD with
other polymorphisms affecting the VDR function, this could probably explains their associa-
tion with several pathological phenotypes [1].
The majority of previous studies dealing with LDD focused specifically on the TaqI poly-
morphism. The first association between TaqI SNP and intervertebral disc disease was reported
in Finnish males [6]. Men with the tt genotype had the lowest prevalence of disc bulges and
fewer lumbar disc herniation in comparison with those with the TT genotype [7]. On the con-
trary, other three Finnish studies found no significant differences in the genotype frequencies
of VDR TaqI between pathological and asymptomatic men, no significant association of the
SNP with Modic changes [8,9] and with lumbar spinal stenosis [10].
Other studies in white Caucasian subjects analyzing TaqI SNP were conducted in Turks
[11,12], Norwegians [13], and Australians [14]. In young Turks no significant differences were
observed in TaqI allele frequencies between patients with hernia or disc degeneration and con-
trols. However, the TT genotype was associated with milder forms, while tt genotype with more
severe forms of disc degeneration. Specifically, TT and Tt genotypes were associated with disc
herniation protrusion, whereas the tt genotype was associated with extrusion/sequestration
[11]. Another study in Turks showed that the presence of VDR TaqI mutation was associated
with a worse disc degeneration score, and with the development of lumbar disc degeneration
[12].
A decrease in the presence of spinal osteophytosis and disc space narrowing from tt to TT
genotypes was observed in Australians [14]. On the contrary, in a Norway case-control study
no association between TaqI SNP and LDD was reported [13].
Three studies on the association of TaqI SNP with LDD were found in Asians [15–17]. In
young Japanese the Tt genotype was associated with an increased risk of severe, multilevel disc
degeneration and herniation and with an early age of the disease onset [15]. In contrast, the fre-
quencies of T and t alleles was not associated with the presence of disc degeneration and osteo-
phyte in elderly Japanese females [16]. In a Chinese study, involving individuals younger than
40 years, the t allele was associated with degenerative disc features and disc bulging [17].
Taking together these results concerning TaqI SNP showed no association of this SNP with
LDD in more than half studies (6/10). Moreover inconsistent findings between studies were
reported, showing an association of TT and tt genotypes in Caucasians, Tt genotype and t allele
in Asians with signs of disc degeneration.
To our knowledge, the great majority of studies concerning lumbar spine pathologies ana-
lyzed the association with TaqI and FokI VDR polymorphisms [18], only 4 studies analyzed
ApaI [15,19–21] and only 2 studies BsmI polymorphism [20,22]. None of the above mentioned
studies performed the analysis of all the 3 RFLP BsmI, ApaI and TaqI polymorphisms at the
same time.
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The A allele of VDR ApaI was significantly associated with LDD with synergistic interaction
between the allele and spine bending/twisting in a Chinese case-control study involving low
back pain patients [19]. Recently, Zawilla et al. found an OR = 3.1 for the association of mutant
ApaI and LDD [21]. Moreover, B allele of VDR BsmI and birthweight were associated with
increasing severity of osteophyte grade in British men with lumbar spine osteoarthritis [22].
Concerning haplotypes, the BsmI-ApaI haplotypes were evaluated in Japanese postmeno-
pausal females affected by lumbar spondylosis [20]. This study observed an association of
BsmI-ApaI VDR haplotypes with the severity of the pathology that was more significant in the
older (>63.6 years) than in the younger subjects [20]. However, differently from the majority
of the studies, in the Japanese study the BsmI and ApaI RFLPs were not in LD.
Differences in ethnicity, inclusion criteria when comparing the same ethnic group, and a
not clear definition of the clinical phenotypes are likely responsible for the inconsistent results
obtained so far. It is also to note that the extent of LD among BsmI, ApaI and TaqI varies in dif-
ferent studies [1], so that the choice to examine only one polymorphism (e.g., TaqI) as repre-
sentative of the other two polymorphisms can possibly be misleading.
Detailed analysis of specific subgroups of LDD patients was performed in an Italian case-
control study published in 2014 by our group [18]. In that study the FF genotype and F allele of
the VDR FokI SNP were associated with an approximately 2-fold risk to develop discopathies,
and particularly discopathies and/or osteochondrosis concomitant with disc herniation [18].
Further, major gender-related effects were observed [23,24].
By analyzing the same cohort of LDD subjects of our previous studies [18, 23], the aim of
the present investigation was to evaluate the distribution of VDR BsmI, ApaI and TaqI allele,
genotype, and haplotype frequencies in patients with specifically defined lumbar spine patholo-
gies in comparison with asymptomatic controls. To our knowledge this is the first study evalu-
ating at the same time all the 3 adjacent polymorphisms in relation to LDD.
Material and Methods
Ethics Statement
The study was approved by the Institutional Review Board ASL Città di Milano, protocol num-
ber GENODISC01. The methods used in this study were in accordance with the Helsinki Dec-
laration of 1975 as revised in 1996.
Subjects and clinical assessment
Based on a case-control design, 266 patients (outpatients or hospitalized) with lumbar spine
disorders recruited for the European Genodisc Project, and 252 asymptomatic controls (most
were healthy volunteers, some were blood donors, few were subjects hospitalized for anterior
cruciate ligament injuries or hallux valgus surgery) were enrolled at the I.R.C.C.S. Istituto Orto-
pedico Galeazzi (Milan, Italy) as previously described [18]. In respect to our previous investiga-
tion [18], the number of controls was increased including 32 additional subjects to have a total
number of controls close to cases.
All subjects signed a written informed consent. Cases and controls were enrolled fromMay
2009 to December 2013. Exclusion criteria for both cases and controls were: pathologic condi-
tion such as cervical discopathies, scoliosis, fibromyalgia, pregnancy at study enrollment, and
chronic diseases like diabetes, cardiovascular diseases, malignancies, lupus erythematosus, and
rheumatoid arthritis. Assessment of lumbar spine disorders and patient’s classification into 4
different mutually exclusive subgroups (designed from 1 to 4 subgroup) based on detailed diag-
nosis were performed by a clinician expert in spine diseases by contrast-enhanced MRI 12
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scans of the lumbar spine with a 1.5 T scanner (Avanto, Siemens, Erlangen, Germany) as
described in our previous paper [18].
Subgroup 1 comprised patients affected by disc herniation only; Subgroup 2 comprised
patients affected by osteochondrosis associated or not with disc hernation; Subgroup 3 com-
prised patients affected by discopathies, osteochondrosis or both without disc herniation;
Subgroup 4 comprised patients affected by stenosis, lytic/isthmic spondylolisthesis, and
degenerative spondylolisthesis.
Due to the close linkage between discopathies, disc herniation and osteochondrosis, a fur-
ther subgroups division from A to D (not mutually exclusive) was performed: Subgroup A,
comprising all herniation cases i. e. Subgroup 1 grouped with Subgroup 2; Subgroup B, includ-
ing all discopathies and/or osteochondrosis regardless of herniation, i.e. Subgroup 2 grouped
with Subgroup 3; Subgroup C, comprising all discopathies concomitant with disc herniation
grouped with subjects with discopathies alone; and Subgroup D, comprising all osteochondro-
sis concomitant with disc herniation grouped with subjects with osteochondrosis alone.
Table 1 reported information for all study subjects including family medical history
(parents, brothers or sisters) about spine disorders, smoking habit, job physical demand for the
majority of the working years (evaluated by the following score: 0 = sedentary; 1 = light;
2 = medium; 3 = heavy), and hours/day spent driving or as a passenger in motorized vehicles
(exposure to vibrations).
Determination of genotypes
Blood samples were collected from the antecubital vein with evacuated ethylenediamine tetra
acetic acid (EDTA) tubes (Vacutainer Tubes, Becton-Dickinson, Franklin Lakes, NJ, USA)
Table 1. Characteristics of the study subjects and comparison of conventional and non-genetic risk factors of lumbar spine pathologies between
controls and all cases or subgroups.
Factors Controls All Cases Subgroup 1 Subgroup 2 Subgroup 3 Subgroup 4
















Gender Males n (%) 127 (50.4) 148 (55.6) 47 (53.4) 55 (63.2)* 21 (52.5) 25 (49.0)
Females n
(%)
125 (40.6) 118 (44.4) 41 (46.6) 32 (36.8) 19 (47.5) 26 (51.0)
BMI (kg/m2) mean ± SD 24.19±3.78 25.29±4.06*** 24.91±4.07 25.27±3.59** 24.29±3.91 26.75
±4.61***
Family history n (%) 37 (14.7) 97 (36.5)*** 33 (37.5)*** 38 (43.7)*** 11 (27.5)* 15(29.4)*
Past and present smoker n (%) 104 (41.3) 144 (54.1)** 53 (60.2)** 50 (57.5)** 16 (40.0) 25 (49.0)
Physical job demand1 (Score
0–3)
mean ± SD 1.06±1.00 1.37±1.08*** 1.39±1.07* 1.38±1.11* 1.40±1.13 1.33±1.05
Exposure to vibrations (Hours/
day)
mean±SD 1.40±1.16 2.20±2.56** 2.33±2.90 2.29±2.43** 2.25±2.80 1.78±1.90
1 5 patients had missing information about intensity of physical demand at work, thus a total of 261 data were available. Physical job demand score used:
0 = sedentary; 1 = light; 2 = medium; 3 = heavy.
Subgroup 1 = patients with disc herniation alone; Subgroup 2 = patients with discopathies and/or osteochondrosis associated with disc herniation;
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from cases and controls. Genomic DNA was extracted from white blood cells according to the
procedure of the DNeasy Midi kit (Qiagen, Duesseldorf, Germany) as described [18]. Polymer-
ase chain reaction and restriction fragment length polymorphism (PCR-RFLP) methods were
applied to detect the BsmI, ApaI, and TaqI polymorphisms of VDR. Genomic DNA was ampli-
fied using PCR. At first DNA was denatured at 95°C for 5 minutes. Standard PCR conditions
for DNA amplification using appropriate primers [25] were as follows: 94°C for 1 minute,
annealing temperature 64°C for 1 minute and 72°C for 2 minutes for 32 cycles and finally 96°C
for 1 minute and 72°C for 5 minutes.
The BsmI, ApaI and TaqI polymorphisms of VDR were studied using previously tested
primers [25] to amplify the first part of intron 8 for BsmI, and a fragment of intron 8/exon 9
for ApaI and TaqI (Fig 1). The allele digested by the restriction enzyme was denoted by a lower
letter, whereas that not digested was indicated by a capital letter.
To analyse the BsmI polymorphism, the resulting amplified 825 bp PCR fragment was
digested with BsmI restriction enzyme (Euroclone, Milano, Italy) generating two fragments of
650 bp and 175 bp in presence of the b allele. Since a mismatched base at the primer binding
region can lead to a drop out of b allele during PCR amplification and to the false higher
Fig 1. Structure of the genomic region of the VDR and location of BsmI, ApaI and TaqI (*in the coding sequence, exon 9) SNPs located near the 3’ terminus
of the gene (a). Representative gels for the determination of BsmI (b), ApaI (c) and TaqI (d) genotypes in three patients are showed. In the first lane there is a
molecular weight DNA ladder (M) for size estimation of the DNA fragments. The letter “A” indicates the PCR amplicons which are of 825 bp for BsmI and 740
bp for ApaI and TaqI. After digestion of the PCR product with BsmI restriction enzyme an undigested 825 bp fragment (homozygous genotype BB), partially
digested 825, 650 and 175 bp fragments (heterozygous genotype Bb), or totally digested 650 and 175 bp fragments (homozygous genotype bb) are present
(b). After digestion of the PCR product with ApaI restriction enzyme an undigested 740 bp fragment (homozygous genotype AA), partially digested 740, 530
and 210 bp fragments (heterozygous genotype Aa), or totally digested 530 and 210 bp fragments (homozygous genotype aa) are present (c). After digestion
of the PCR product with TaqI restriction enzyme, digested 495 and 245 bp fragments (homozygous genotype TT), partially digested 495, 290, 245 and 205
bp fragments (heterozygous genotype Tt), or totally digested 290, 245 and 205 bp fragments (homozygous genotype tt) are present (d). All the images of the
original gels from which we cropped the representative images showed in Fig 1 are available as S1–S6 Figs.
doi:10.1371/journal.pone.0155004.g001
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prevalence of BB genotype [26], data obtained with PCR-RFLP were confirmed using Taq-
Man1 SNP Genotyping Assay (Life Technologies, Carlsbad, CA, USA) for rs1544410. A higher
number of Bb subjects with a proportionally smaller number of BB subjects were observed after
application of the genotyping assay. Specifically, out of the 141 subjects having the BB genotype
assigned with PCR-RFLP, 48 subjects were assigned as Bb, and 2 as bb after the analysis with
the TaqMan1 SNP Genotyping Assay.
ApaI digestion of the 740 bp amplified DNA used to determine both ApaI and TaqI RFLP,
resulted in two fragments of 530 bp and 210 bp in presence of the a allele.
Digestion with TaqI of the 740 bp PCR fragment resulted in three fragments of 290 bp, 245
bp and 205 bp in presence of the t allele, and in two fragments of 495 bp and 245 bp in its
absence (T allele) due to an additional monomorphic TaqI site.
DNA fragments were separated by electrophoresis on polyacrylamide gel.
Genotypes were designated by a lowercase letter (b, a, t alleles) for the presence of the
restriction enzyme site, and by a capital letter (B, A, T alleles) for its absence.
Statistical analysis
Kolmogorov-Smirnov and Shapiro-Wilk tests were used to assess the normality of data distri-
bution. Since data were not normally distributed, Mann Whitney test were used to assess the
differences between continuous variables such as age, BMI, physical job demand, and exposure
to vibration in all cases or subgroups and controls. For categorical variables, Odds ratios (ORs)
and the 95% confidence interval (CI) were calculated to evaluate the risk of spine pathologies
by comparing cases or subgroups of patients with controls, significance was evaluated by chi
square Pearson or Fisher exact test, as appropriate (for clarity we showed in Table 1 only signif-
icance and not all ORs and CIs).
Tests for deviations from Hardy-Weinberg equilibrium (HWE) were performed using a
chi-square distribution in all the subjects, and in cases and controls separately for each SNP.
ORs and the CI were calculated to set the association between alleles, genotypes, and haplo-
types and risk of spine pathologies in cases, controls and subgroups of patients. Logistic regres-
sion was used to evaluate effects of confounders by obtaining adjusted ORs and 95% CIs for
genotypes and alleles. Adjusted analysis included conventional risk factors previously observed
[18] and confirmed in this cohort such as: age, BMI, smoke, physical job demand and exposure
to vibrations (Table 1). Family history was not included as confounder to avoid overcorrection
by considering that it includes genetic hereditary components. Throughout the text adjusted
ORs for the genetic associations were reported.
Eight rare BsmI-ApaI-TaqI haplotypes estimated to be less than 3% in frequency in both
cases and controls (including in total 11 subjects) were not reported. LD between the SNPs was
determined using Haploview [27]. Haplotype frequencies were estimated with the program
CHAPLIN [28].
Significance level was held at 0.05, and P values 0.10 were considered as a tendency. Sta-
tistical softwares used were GraphPad Prism version 5.00 (GraphPad software, La Jolla, CA,
USA), and SPSS version 14.0 (SPSS Inc., Chicago, IL, USA).
Results
VDR BsmI, ApaI, TaqI genotypes and alleles
In our total sample the frequency of BB was 17.6% (91/518), Bb was 51.3% (266/518), and bb
was 31.1% (161/518). B allele had a frequency of 43.2% (448/1036), and the b allele had a fre-
quency of 56.8% (588/1036). The observed BsmI genotype frequencies were in HWE (X2 =
1.102, P = 0.29). In particular, controls did not deviate (X2 = 0.943, P = 0.33), while cases (X2 =
BsmI, ApaI and TaqI VDR Variants in Spine Pathologies
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6.043, P = 0.01) deviated from HWE. The frequency of AA genotype was 34.0% (176/518), Aa
was 48.1% (249/518), and aa was 17.9% (93/518). A allele had a frequency of 58.0% (601/
1036), and the a allele had a frequency of 42.0% (435/1036). The observed ApaI genotype fre-
quencies were consistent with HWE (X2 = 0.091, P = 0.76). Neither controls (X2 = 3.67,
P = 0.05) nor cases (X2 = 2.09, P = 0.15) deviated from HWE. The frequency of TT genotype
was 42.5% (220/518), Tt was 43.6% (226/518), and tt was 13.9% (72/518). T allele had a fre-
quency of 64.3% (666/1036), and the t allele had a frequency of 35.7% (370/1036). The
observed TaqI genotype frequencies were consistent with HWE (X2 = 1.287, P = 0.26). Neither
controls (X2 = 1.058, P = 0.30) nor cases (X2 = 0.33, P = 0.56) deviated from HWE.
In S1 Appendix were reported the frequencies of BsmI, ApaI and TaqI genotypes in cases
and controls.
Tables 2 and 3, respectively, illustrated frequencies of BsmI, ApaI and TaqI genotypes and
alleles in controls compared with overall LDD cases, and specific subgroups of patients.
By comparison of controls with all LDD cases, significant differences were observed for the
heterozygous Bb and Aa genotypes (OR = 1.62, 95%CI = 1.11–2.36, P = 0.012, and OR = 1.60,
95%CI = 1.10–2.33, P = 0.014, respectively), while the homozygous bb genotype was protective
(OR = 0.56, 95%CI = 0.37–0.84, P = 0.005).
By specific subgroups analysis, the Bb genotype was a risk factor for disc herniation (subgroup
1, OR = 1.97, 95%CI = 1.16–3.36, P = 0.013; subgroup 1+2+3, OR = 1.73, 95%CI = 1.16–2.56,
P = 0.007; and subgroup A, OR = 1.67, 95%CI = 1.10–2.55, P = 0.017). On the contrary, the bb
genotype was protective for almost all the subgroups (subgroup 1, OR = 0.40, 95%CI = 0.21–
0.74, P = 0.004; subgroup 3, OR = 0.40, 95%CI = 0.17–0.95, P = 0.037; subgroup 1+2+3,
OR = 0.54, 95%CI = 0.35–0.83, P = 0.005; subgroup A, OR = 0.57, 95%CI = 0.36–0.91, P = 0.018;
and subgroup C, OR = 0.40, 95%CI = 0.20–0.82, P = 0.012). Patients with osteochondrosis with
Table 2. Association of lumbar spine pathologies and VDRBsmI, ApaI, and TaqI genotypes.
BB Bb bb AA Aa aa TT Tt tt
Controls n = 252 (%) 45 (17.9) 114 (45.2) 93 (36.9) 92 (36.5) 108 (42.9) 52 (20.6) 106 (42.1) 109 (43.2) 37 (14.7)
Cases n = 266 (%) 46 (17.3) 152 (57.1)** 68 (25.6)** 84 (31.6) 141 (53.0)* 41 (15.4)^ 114 (42.9) 117 (44.0) 35 (13.1)
Subgroup 1 n = 88 (%) 15 (17.0) 54 (61.4)** 19 (21.6)** 26 (29.5) 51 (58.0)* 11 (12.5)* 37 (42.0) 40 (45.5) 11 (12.5)
Subgroup 2 n = 87 (%) 12 (13.8) 46 (52.9) 29 (33.3) 23 (26.4)^ 50 (57.5)^ 14 (16.1) 43 (49.4) 34 (39.1) 10 (11.5)
Subgroup 3 n = 40 (%) 9 (22.5) 23 (57.5)^ 8 (20.0)* 16 (40.0) 20 (50.0) 4 (10.0) 12 (30.0) 21 (52.5) 7 (17.5)
Subgroup 4 n = 51 (%) 10 (19.6) 29 (56.9) 12 (23.5)^ 19 (37.3) 20 (39.2) 12 (23.5) 22 (43.1) 22 (43.1) 7 (13.8)
Subgroup 1+2+3 n = 215 (%) 36 (16.7) 123 (57.2)** 56 (26.0)* 65 (30.2) 121 (56.3)** 29 (13.5)* 92 (42.8) 95 (44.2) 28 (13.0)
Subgroup A n = 175 (%) 27 (15.4) 100 (57.2)* 48 (27.4)* 49 (28.0)^ 101 (57.7)** 25 (14.3)* 80 (45.7) 74 (42.3) 21 (12.0)
Subgroup B n = 127 (%) 21 (16.5) 69 (54.3)^ 37 (29.1)^ 39 (30.7) 70 (55.1)^ 18 (14.2) 55 (43.3) 55 (43.3) 17 (13.4)
Subgroup C n = 64 (%) 17 (26.6) 34 (53.1) 13 (20.3)* 27 (42.2) 28 (43.7) 9 (14.1) 22 (34.4) 27 (42.2) 15 (23.4)^
Subgroup D n = 50 (%) 3 (6.0)^ 26 (52.0) 21 (42.0) 7 (14.0)** 34 (68.0)** 9 (18.0) 29 (58.0)^ 21 (42.0) 0 (0)*
Subgroup 1 = patients with disc herniation alone; Subgroup 2 = patients with discopathies and/or osteochondrosis associated with disc herniation;
Subgroup 3 = patients with discopathies and/or osteochondrosis without herniation; Subgroup 4 = patients with stenosis and/or spondylolisthesis.
Subgroup A, Subgroup 1 grouped with Subgroup 2 (i.e. all hernia cases with or without concomitant additional conditions); Subgroup B, Subgroup 2
grouped with Subgroup 3; Subgroup C, all discopathies cases with or without concomitant disc herniation; Subgroup D, all osteochondrosis cases with or
without concomitant disc herniation.
* P<0.05,
** P<0.01
^ P  0.10
doi:10.1371/journal.pone.0155004.t002
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or without disc herniation showed an opposite trend, in fact, the BB genotype had a tendency to
be protective (subgroup D, OR = 0.30, 95%CI = 0.09–1.08, P = 0.065).
The Aa genotype was a risk factor for disc herniation (subgroup 1, OR = 1.95, 95%
CI = 1.15–3.32, P = 0.014; subgroup 1+2+3, OR = 1.76, 95%CI = 1.19–2.61, P = 0.005; and sub-
group A, OR = 1.88, 95%CI = 1.23–2.88, P = 0.003). On the contrary, the aa genotype was pro-
tective for 2 subgroups (subgroup 1+2+3, OR = 0.52, 95%CI = 0.30–0.91, P = 0.021; subgroup
A, OR = 0.55, 95%CI = 0.30–0.98, P = 0.043). For subgroup D (all osteochondrosis cases) the
Aa genotype was a risk factor (OR = 2.70, 95%CI = 1.37–5.34, P = 0.004), while the AA geno-
type was protective (OR = 0.31, 95%CI = 0.13–0.73, P = 0.008). Finally, for the subgroup D
only, the tt genotype was protective.
From the analysis of alleles distributions in pathological subgroups it was observed that B
allele was a risk factor to develop discopathies with or without disc herniation (subgroup C,
crude OR = 1.66, 95%CI = 1.10–2.51, P = 0.017), and the T allele was risky for all osteochon-
drosis (subgroup D, OR = 2.09, 95%CI = 1.21–3.61, P = 0.008).
For patients with stenosis and/or spondylolistesis no significant findings were obtained
regarding genotypes and alleles.
VDR BsmI, ApaI, TaqI haplotypes
LD plots (r2) showed that all the three SNPs were in linkage disequilibrium (Fig 2). The stron-
gest LD was observed between ApaI and TaqI (r2 = 0.95 in all the subjects, r2 = 0.93 in controls,
and r2 = 0.98 in cases). TaqI and BsmI showed slightly lower values of LD (r2 = 0.94 in all the
subjects, r2 = 0.93 in controls, and r2 = 0.95 in cases), while BsmI and ApaI showed the lowest
values (r2 = 0.87 in all the subjects, r2 = 0.90 in controls, r2 = 0.85 in cases).
Table 4 reported the frequencies of BsmI, ApaI and TaqI combined genotypes in controls
compared with overall cases and specific subgroups of patients.
Table 3. Association of lumbar spine pathologies and VDRBsmI, ApaI, and TaqI alleles.
B b A a T t
Controls n = 252 (%) 204/504 (40.5) 300/504 (59.5) 292/504 (57.9) 212/504 (42.1) 321/504 (63.7) 183/504 (36.3)
Cases n = 266 (%) 244/532 (45.9)^ 288/532 (54.1)^ 309/532 (58.1) 223/532 (41.9) 345/532 (64.8) 187/532 (35.1)
Subgroup 1 n = 88 (%) 84/176 (47.7)^ 92/176 (52.3)^ 103/176 (58.5) 73/176 (41.5) 114/176 (64.8) 62/176 (35.2)
Subgroup 2 n = 87 (%) 70/174 (40.2) 104/174 (59.8) 96/174 (55.2) 78/174 (44.8) 120/174 (69.0) 54/174 (31.0)
Subgroup 3 n = 40 (%) 41/80 (51.2)^ 39/80 (48.8)^ 52/80 (65.0) 28/80 (35.0) 45/80 (56.3) 35/80 (43.7)
Subgroup 4 n = 51 (%) 49/102 (48.0) 53/102 (52.0) 58/102 (56.9) 44/102 (43.1) 66/102 (64.7) 36/102 (35.3)
Subgroup 1+2+3 n = 215 (%) 195/430 (45.3) 235/430 (54.7) 251/430 (58.4) 179/430 (41.6) 279/430 (64.9) 151/430 (35.1)
Subgroup A n = 175 (%) 154/350 (44.0) 196/350 (56.0) 199/350 (56.9) 151/350 (43.1) 234/350 (66.9) 116/350 (33.1)
Subgroup B n = 127 (%) 111/254 (43.7) 143/254 (56.3) 148/254 (58.3) 106/254 (41.7) 165/254 (65.0) 89/254 (35.0)
Subgroup C n = 64 (%) 68/128 (53.1)* 60/128 (46.9)* 82/128 (64.1) 46/128 (35.9) 71/128 (55.5)^ 57/128 (44.5)^
Subgroup D n = 50 (%) 32/100 (32.0) 68/100 (68.0) 48/100 (48.0)^ 52/100 (52.0)^ 79/100 (79.0)** 21/100 (21.0)**
Subgroup 1 = patients with disc herniation alone; Subgroup 2 = patients with discopathies and/or osteochondrosis associated with disc herniation;
Subgroup 3 = patients with discopathies and/or osteochondrosis without herniation; Subgroup 4 = patients with stenosis and/or spondylolisthesis.
Subgroup A, Subgroup 1 grouped with Subgroup 2 (i.e. all hernia cases with or without concomitant additional conditions); Subgroup B, Subgroup 2
grouped with Subgroup 3; Subgroup C, all discopathies cases with or without concomitant disc herniation; Subgroup D, all osteochondrosis cases with or
without concomitant disc herniation.
* P<0.05,
** P<0.01
^ P  0.10
doi:10.1371/journal.pone.0155004.t003
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From the frequency distributions of the 10 identified combined genotypes we observed that
the BbAaTT was 3-fold more frequent in all LDD cases (OR = 3.38, 95%CI = 1.49–7.67,
P = 0.004), and had significant OR = 4.44, 95%CI = 1.62–12.2, P = 0.004 for subgroup 1;
OR = 3.16, 95%CI = 1.07–9.33, P = 0.038 for subgroup 2; OR = 3.44, 95%CI = 1.48–7.97,
P = 0.004 for subgroup 1+2+3; OR = 3.85, 95%CI = 1.60–9.28, P = 0.003 for subgroup A; and
OR = 2.81, 95%CI = 1.07–7.42, P = 0.036 for subgroup B. The bbaaTT was protective for all
cases (OR = 0.47, 95%CI = 0.27–0.82, P = 0.008), and specifically for subgroup 1, OR = 0.24,
95%CI = 0.09–0.66, P = 0.006; subgroup 3, OR = 0.20, 95%CI = 0.04–0.90, P = 0.036; subgroup
1+2+3, OR = 0.39, 95%CI = 0.21–0.72, P = 0.003; and subgroup A, OR = 0.43, 95%CI = 0.23–
Fig 2. LD plots (r2) are shown for all subjects (a), controls (b) and cases (c).
doi:10.1371/journal.pone.0155004.g002
Table 4. Association of lumbar spine pathologies and VDRBsmI, ApaI, and TaqI combined genotypes.
Genotypes BbAaTt bbaaTT BBAAtt BbAATt bbAaTT bbAATT BBAATt BbAaTT BbAATT BbaaTT
Controls n = 252 (%) 66 (26.2) 47 (18.6) 34 (13.5) 29 (11.5) 28 (11.1) 13 (5.2) 10 (4.0) 9 (3.6) 5 (2.0) 4 (1.6)
Cases n = 266 (%) 79 (29.7) 29 (10.9)* 32 (12.0) 23 (8.6) 35 (13.2) 3 (1.1)* 13 (4.9) 26 (9.8)** 10 (3.8) 11 (4.1)^
Subgroup 1 n = 88 (%) 29 (32.9) 7 (7.9)* 10 (11.4) 6 (6.8) 11 (12.5) 1 (1.1) 5 (5.7) 11 (12.5)** 3 (3.4) 4 (4.5)
Subgroup 2 n = 87 (%) 26 (30.0) 12 (13.8) 8 (9.2) 4 (4.6)^ 15 (17.2) 2 (2.3) 3 (3.4) 8 (9.2)* 4 (4.6) 2 (2.3)
Subgroup 3 n = 40 (%) 12 (30.0) 2 (5.0)* 7 (17.5) 6 (15.0) 5 (12.5) 0 (0) 2 (5.0) 3 (7.5) 1 (2.5) 1 (2.5)
Subgroup 4 n = 51 (%) 12 (23.5) 8 (15.7) 7 (13.7) 7 (13.7) 4 (7.8) 0 (0) 3 (5.9) 4 (7.8)^ 2 (3.9) 4 (7.8)^
Subgroup 1+2+3 n = 215 (%) 67 (31.2) 21 (9.8)** 25 (11.6) 16 (7.4) 31 (14.4) 3 (1.4)^ 10 (4.6) 22 (10.2)** 8 (3.7) 7 (3.2)
Subgroup A n = 175 (%) 55 (31.4) 19 (10.9)* 18 (10.3) 10 (5.7)^ 26 (14.9) 3 (1.7)^ 8 (4.6) 19 (10.9)** 7 (4.0) 6 (3.4)
Subgroup B n = 127 (%) 38 (29.9) 14 (11.0)^ 15 (11.8) 10 (7.9) 20 (15.7) 2 (1.6)^ 5 (3.9) 11 (8.7)* 5 (3.9) 3 (2.4)
Subgroup C n = 64 (%) 16 (25.0) 6 (9.4)^ 14 (21.9)^ 7 (10.9) 6 (9.4) 0 (0)^ 2 (3.1) 5 (7.8)^ 3 (4.7) 2 (3.1)
Subgroup D n = 50 (%) 17 (34.0) 8 (16.0) 0 (0) 1 (2.0)^ 12 (24.0)* 1 (2.0) 3 (6.0) 5 (10.0)^ 2 (4.0) 1 (2.0)
Subgroup 1 = patients with disc herniation alone; Subgroup 2 = patients with discopathies and/or osteochondrosis associated with disc herniation;
Subgroup 3 = patients with discopathies and/or osteochondrosis without herniation; Subgroup 4 = patients with stenosis and/or spondylolisthesis.
Subgroup A, Subgroup 1 grouped with Subgroup 2 (i.e. all hernia cases with or without concomitant additional conditions); Subgroup B, Subgroup 2
grouped with Subgroup 3; Subgroup C, all discopathies cases with or without concomitant disc herniation; Subgroup D, all osteochondrosis cases with or
without concomitant disc herniation.
* P<0.05,
** P<0.01
^ P  0.10
doi:10.1371/journal.pone.0155004.t004
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0.83, P = 0.012. The bbAATT was protective for all cases (OR = 0.22, 95%CI = 0.06–0.80,
P = 0.022), and showed a protective tendency for all the discopathies, i.e. subgroup 1+2+3,
OR = 0.27, P = 0.051, and for subgroup A, OR = 0.32, P = 0.086.
Finally, the bbAaTT was risky (OR = 2.56, 95%CI = 1.10–5.97, P = 0.030) only for subgroup
D, i. e., for all patients with osteochondrosis, a subgroup with a peculiar pathological
phenotype.
For patients with stenosis and/or spondylolistesis no significant findings were obtained
regarding haplotypes.
Estimated haplotype frequencies were shown in Table 5. The most represented haplotype in
the whole cohort of controls and cases was baT, followed by BAt and bAT.
Discussion
To the best of our knowledge, this is the first study demonstrating an association between the
three VDR BsmI, ApaI and TaqI variants and clearly defined lumbar spine pathologies, and the
only one study performed in the Italian population.
Genotype and allele frequencies were closed to those of Italian subjects from Central Italy
reported in HapMap (101 subjects: genotypes BB = 17.8%, Bb = 48.5%, bb = 33.7%, alleles
B = 42.1%, b = 57.9%; 102 subjects: genotypes AA = 36.3%, Aa = 45.1%, aa = 18.6%, alleles
A = 58.8%, a = 41.2%; 101 subjects: genotypes TT = 33.7%, Tt = 48.5%, tt = 17.8%, alleles
T = 57.9%, t = 42.1%) [29].
The distribution of genotypes and alleles in our cohort of controls was in accordance also
with data of controls reported in a meta-analysis, based on studies published till December
2005, that investigated the association between these VDR polymorphisms and the risk of oste-
oporosis in Caucasian, East Asian, Mexican, Latino and Turkish women [30].
The heterozygous Bb and Aa genotypes represented a risk factor, while the homozygous bb
genotype was protective for the all subjects with lumbar spine pathologies recruited in our
study.
Table 5. Estimated frequencies of VDRBsmI, ApaI, and TaqI haplotypes.
Haplotypes baT BAt bAT BAT bAt BaT
Controls n = 252 101 (40.4) 86 (34.4) 44 (17.6) 12 (4.8) 2 (1.1) 2 (1.0)
Cases n = 266 103 (38.9) 91 (34.3) 38 (14.4) 23 (8.8) 1 (0.6) 7 (2.8)
Subgroup 1 n = 88 34 (38.7) 30 (34.6) 11 (13.0) 9 (10.3) 0 (0.6) 2 (2.8)
Subgroup 2 n = 87 37 (42.7) 25 (29.8) 13 (15.9) 7 (8.3) 1 (1.2) 1 (2.2)
Subgroup 3 n = 40 12 (32.0) 16 (42.4) 6 (15.4) 2 (7.2) 0 (0) 0 (1.6)
Subgroup 4 n = 51 19 (35.6) 17 (35.3) 6 (13.4) 4 (8.2) 0 (0) 2 (4.6)
Subgroup 1+2+3 n = 215 83 (39.0) 73 (34.1) 31 (14.6) 19 (8.9) 1 (0.8) 5 (2.3)
Subgroup A n = 175 71 (40.6) 56 (32.2) 25 (14.4) 16 (9.3) 1 (0.9) 4 (2.5)
Subgroup B n = 127 49 (39.3) 42 (33.7) 19 (15.7) 10 (8.0) 1 (0.9) 2 (2.0)
Subgroup C n = 64 20 (32.2) 27 (42.8) 8 (13.0) 4 (7.4) 0 (0.9) 1 (2.9)
Subgroup D n = 50 25 (50.8) 10 (21.0) 8 (17.2) 4 (9.8) 0 (0) 0 (1.2)
Subgroup 1 = patients with disc herniation alone; Subgroup 2 = patients with discopathies and/or osteochondrosis associated with disc herniation;
Subgroup 3 = patients with discopathies and/or osteochondrosis without herniation; Subgroup 4 = patients with stenosis and/or spondylolisthesis.
Subgroup A, Subgroup 1 grouped with Subgroup 2 (i.e. all hernia cases with or without concomitant additional conditions); Subgroup B, Subgroup 2
grouped with Subgroup 3; Subgroup C, all discopathies cases with or without concomitant disc herniation; Subgroup D, all osteochondrosis cases with or
without concomitant disc herniation.
doi:10.1371/journal.pone.0155004.t005
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Other studies showed an association between BsmI, ApaI and TaqI VDR genotypes or alleles
and signs of disc degeneration such as bulges, osteophytosis, disc space narrowing or disc her-
niation. In particular B allele in British [22], genotypes TT in Finnish [7], Tt and tt in Turkish
[11,12] and Australian [14], Tt in Japanese [15] and alleles t and A in Chinese [17,19] patients
were reported as predisposing towards worse phenotypes.
The inconsistent findings between our study and the data reported in literature [31] are
likely related to both the ethnic differences among the study populations and to the different
inclusion criteria, as well as to the lack of a standardized approach to define pathological phe-
notypes [32,33].
In our study, after the analysis of the overall cohort of LDD patients, we classified our cases
in subgroups of clinical relevance, according to specific pathological features revealed by MRI.
This approach allowed us to better define whether the associations of variants observed in all
the pathological subjects were true for all the subgroups or only for particular lumbar spine
pathologies.
The results were confirmed after adjusting for previously identified conventional low back
pain risk factors [18]. Data observed for the overall cohort of subjects were confirmed for par-
ticular subgroups of patients. Bb genotype and B allele were associated with a 1.66 to 1.97-fold
increased risk to develop disc herniation and discopathies concomitant or not with disc hernia-
tion. On the contrary, bb genotype was protective. Aa genotype was also associated with a 1.76
to 1.95-fold increased risk to develop discopathies and/or osteochondrosis associated or not
with disc herniation, while aa genotype was protective.
Interestingly, the subgroup of patients with osteochondrosis showed particular features. Aa
genotype was a risk factor (2.70-fold increased risk), while AA genotype was protective for this
condition. In this subgroup of patients an opposite trend for BsmI was observed with respect to
other patients, with a protective tendency for BB genotype. In the same subgroup, the T allele
represented a 2.09-fold increased risk to develop osteochondrosis, while tt genotype was highly
protective.
The three SNPs analyzed in our study were in high LD, where the greatest degree of LD was
found between ApaI and TaqI, followed by TaqI and BsmI, and then BsmI and ApaI. A differ-
ent trend was reported in the meta-analysis of Thakkinstian et al. [34], where the greatest
degree of LD was observed between the BsmI and TaqI polymorphisms, followed by BsmI and
ApaI, and then ApaI and TaqI. These discrepancies are likely related to the absence of HWE
for all the three sites in one study [35] and for BsmI in another one [36] described in the meta-
analysis, while our observed genotype frequencies were consistent with HWE.
The frequency distributions of the combined genotypes in our controls were close to those
of non-osteoporotic postmenopausal women from Belgium [35], Italy [37], Denmark [36] and
the Netherlands [38], and our estimated haplotype frequencies showed that the most common
haplotype was baT, followed by BAt and bAT as reported for Caucasian women [34].
By excluding too rare combined genotypes (estimated to be less than 3% in frequency), we
identified ten combined genotypes, among which notably the BbAATT had not been described
before. Of these combinations, four were particularly interesting since they were associated
with specific clinical conditions. The BbAaTT was risky (OR ranging from 2.81 to 4.44), while
the bbaaTT and bbAATT were protective for patients with disc herniation and discopathies. As
observed for genotypes and alleles, even for combined genotype analysis, the subgroup of
patients with osteochondrosis showed peculiar features; in fact, the bbAaTT combined geno-
type had a 2.56-fold risk to develop osteochondrosis, a degenerative process involving primar-
ily the vertebral bodies structures limiting the disc [39].
No significant findings were obtained regarding alleles, genotypes and haplotypes for
patients with stenosis and/or spondylolistesis.
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Interesting results were found for all the three SNPs BsmI, ApaI and TaqI, when analyzed in
the light of clinical relevant phenotypes. In summary, patients affected by disc herniation and
discopathies and/or osteochondrosis associated or not with disc herniation showed risky B
allele, Bb, Aa, BbAaTT genotypes, and protective bb, aa, bbaaTT, bbAATT genotypes. In
patients with osteochondrosis, T allele, Aa, TT, bbAaTT genotypes were risky, while t allele,
AA, tt genotypes were protective.
The bbaaTT genotype, the main protective combined genotype for spine pathologies
observed in our study, was more prevalent also in 144 non-osteoporotic Italian postmeno-
pausal women compared to 176 osteoporotic subjects [37].
It is to note that, in our cohort, the TT genotype was risky or protective depending on the
specific haplotype to which it belonged. This could explain the discrepancies between studies
which evaluated only the TaqI polymorphism without a further haplotype analysis.
In the future, it will be our interest to enlarge the group of controls and the pathological sub-
groups to confirm present results in a larger cohort of subjects. This is particularly important
since in large studies no association between these 3 VDR polymorphisms and the risk of osteo-
porosis [30], vertebral fracture incidence in women [40] and osteoarthritis in European popu-
lation [41] was observed.
Moreover, basic science studies should be performed to reach a deeper knowledge of the
molecular mechanism regulated by vitamin D through its receptor in the spine tissues. This
will help to understand the association between these 3 SNPs in non-coding VDR sequence
and spine pathologies. Particularly, it will be useful to study the interaction of BsmI, ApaI and
TaqI VDR variants and other SNPs in nearby functional genes supposed to be in LD, such as
collagen type II alpha 1 (COL2A1) [42], whose gene product is abundantly present in the
intervertebral disc [43], and whose expression is regulated by vitamin D active metabolites
[44].
Nevertheless our results highlighted the importance to perform a clear clinical evaluation of
the patients with lumbar spine pathologies to obtain specific phenotypes for the identification
of genetic markers of pathology. Moreover, the presence of specific genotypes/alleles/haplo-
types associated with defined phenotypes suggests the possibility of a personalized clinical
approach aimed to prevent or at least to delay the development of these spine disorders.
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